Cardioline acquires Cardios, creating a broad global leadership in cardiac diagnostics.

Strategic combination unites Cardioline's global reach and proven cardiac technology with Cardios's decades of clinical expertise in Holter monitoring and ABPM.

São Paulo, Brazil, April 30, 2026 - Cardioline, a globally recognized leader in cardiac diagnostic solutions and pioneer in telecardiology, providing connected cardiac care solutions for physicians and patients in more than 85 countries, today announces the successful acquisition of Cardios, in São Paulo, Brazil, from Halma. Cardios is a highly respected and innovative company in Holter monitoring and ambulatory blood pressure monitoring (ABPM) with a decades-long track record of clinical reliability in Brazil. The transaction, supported by ARCHIMED, represents a transformative milestone for both organizations, accelerating Cardioline's telecardiology strategy and opening a new chapter for advancing even more comprehensive, connected, and patient-centered care worldwide.

The acquisition brings together two organizations whose complementary strengths span the entire cardiac diagnostics journey. Cardioline's full portfolio, already established internationally, will be further strengthened by Cardios's regional expertise in Holter and ABPM technologies. Together, the companies are now positioned to offer physicians, healthcare institutions, and patients in global markets a broader and more integrated set of cardiac diagnostics solutions.

ARCHIMED, a healthcare-specialized private equity firm and majority shareholder of Cardioline, played a central role in enabling this transaction. The acquisition reflects ARCHIMED's ongoing commitment to building leading, scalable platforms in medtech and healthcare services, as well as driving Cardioline's growth strategy under its stewardship. This milestone also reflects the strong foundation Halma built with Cardios over the years. Its leadership gave rise to a business of exceptional clinical quality and commercial strength, and Cardioline is proud to continue building on that legacy.

“This acquisition is a very important moment for Cardioline and a clear expression of our vision: driving better cardiac care at a global scale. Over decades, Cardios has earned an exceptional reputation for accuracy and reliability, and its deep expertise in Holter and ABPM perfectly complements our global portfolio. Together, we are creating an end-to-end solution that will truly support every step of the cardiac care journey.

This transaction also significantly strengthens Cardioline's leadership position in telemedicine. Beyond product synergy, the acquisition opens a new relevant geographic hub for Cardioline, expanding our presence and commercial reach in markets where Cardios has built strong, trusted relationships. This is exactly the kind of strategic growth we set out to achieve with ARCHIMED's support, grounded in clinical fundamentals, with geographic expansion, and deeply aligned with our values. We are proud to welcome the Cardios team to the Cardioline family.”

Luis Meireles, CEO, Cardioline

“This integration marks an exciting and transformative moment in Cardios's journey, now incorporating Cardioline's established solutions, especially in stress testing systems and electrocardiography, expanding our ability to deliver more comprehensive and integrated care throughout the clinical journey. By combining Cardioline's global reach with the clinical expertise, market proximity, and trust built by Cardios in Holter and ABPM over decades, we strengthen our shared goal of redefining standards in cardiac diagnostics and generating a positive and lasting impact for physicians, healthcare institutions, and patients, transforming innovation into solutions that make a difference in saving lives.”

Erica Chriguer, CEO, Cardios

About Cardioline

Cardioline is a globally recognized manufacturer of cardiac diagnostic equipment, specializing in ECG systems, exercise stress testing platforms, and integrated cardiology solutions. With a legacy of innovation built over decades, Cardioline serves healthcare professionals and institutions in more than 85 countries, delivering technology that drives clinical accuracy and reliable outcomes for patients. Cardioline is an ARCHIMED company.

About Cardios

Cardios is a leader in Holter monitoring and ambulatory blood pressure monitoring (ABPM) solutions, built on decades of clinical expertise and a reputation for trust among healthcare professionals and institutions. Recognized for its reliability and closeness to the clinical market, Cardios has become a benchmark in long-term cardiac monitoring for patients and institutions throughout Brazil.

About ARCHIMED

With offices in Europe, North America, and Asia, ARCHIMED is a leading investment firm focused exclusively on the healthcare sectors. Its combination of operational, medical, scientific, and financial expertise enables it to act as a strategic and financial partner to companies in the sector. Its priority areas include Animal and Environmental Health, Biopharmaceutical Products, Consumer Health, Diagnostics, Health Information Technology, Life Sciences Tools and Services, and MedTech. ARCHIMED helps its partners internationalize, acquire, innovate, and expand their products and services. It manages €9 billion across its various funds. Since its founding, it has operated as a committed impact investor, both directly and through its EURÊKA Foundation.